Article History
Accepted: 7 December 2023
First Online: 22 December 2023
Declarations
:
: TF disclosures are as follows: Horizon Pharmaceuticals (payment for consulting on gout exhibit), Avion Pharmaceuticals (Advisory Board), and Novartis Pharmaceuticals (payment for consultation). Authors KY, LY, and GB declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.